Cancer drug sales give Roche a boost
Swiss pharmaceuticals group Roche beat market expectations with net income up 4 per cent to $2.5bn for the first half of 2005, on the back of strong cancer and flu drug sales. The results helped push
Swiss pharmaceuticals group Roche beat market expectations with net income up 4 per cent to $2.5bn for the first half of 2005, on the back of strong cancer and flu drug sales. The results helped push